CTRI/2017/08/009440已完成3 期
To Evaluate the Role of Intralesional Propranolol for treatment of periorbital and eyelid capillary haemangiomas as compared with Oral Propranolol
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Newly diagnosed cases of periorbital and eyelid capillary haemangiomas
- •2 Only those patients or whose guardians sign a written informed consent
- •3 No complications like ulceration/ necrosis
- •4 No previous intervention
- •5 No history of any systemic illness including asthma/ heart disease/ diabetes mellitus
- •6 No history of developmental delay
排除标准
- •1 Patients not willing for treatment or follow up
- •2 Previously treated patients
- •3 Presence of systemic illnesses including recurrent breathing problem/ asthma; cardiac problems including AV block, CHF, sinus bradycardia; history of seizures; history of diabetes mellitus
- •-Abnormalities found in blood investigations
- •-Failure to get Cardiology Clearance for the intervention
- •-Additional ocular pathologies
研究者
相似试验
招募中
3 期
effect of Propranolol in Traumatic Brain Injury (TBI)IRCT20130310012776N4Shiraz University of Medical Sciences110
招募中
1 期
Evaluating the effect of oral Propranolol in preventing the progression of retinopathy of prematurityretinopathy of prematurity.Retinopathy of prematurity, unspecified, bilateralH35.103IRCT20230717058817N1Ardabil University of Medical Sciences66
已完成
2 期
to evaluate Efficacy and Safety of oral Propranolol in enlarging Hemangioma in children less than one year.CTRI/2013/09/003975GCS Medical College and research centre
已完成
不适用
Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity (PROP-ROP)Retinopathy of prematurity (ROP), the leading cause of blindness in childrenNeonatal DiseasesOther retinal disordersISRCTN18523491A. Meyer University Children's Hospital (Italy)44
已完成
2 期
Oral propranolol and retinopathy of prematurityRetinopathy of prematurityIRCT20100512003915N21Tabriz University of Medical Sciences72